Author

Zahra Khan

Memorial Sloan Kettering Cancer CenterPrimary ORCID profile (0000-0001-5295-8286 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Zahra KhaniD1 paper · Gachon University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Charles L. SawyersiD· 2 shared Nikolaus D. SchultziD· 2 shared Subhiksha NandakumariD· 2 shared Alexandre Gaspar‐MaiaiD· 1 shared Cláes DahlgreniD· 1 shared Emmet Huang-HobbsiD· 1 shared Fariha KhaniD· 1 shared Huamei Fu ForsmaniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Charles L. SawyersORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 8, 2026

MYC pathway reprogramming through a TIP60 coactivator switch in neuroendocrine lineage transition in prostate cancer

Zhen Sun, Jimmy Zhao, Zahra Khan…·Charles L. Sawyers

The paper identifies a TIP60 coactivator switch in neuroendocrine prostate cancer, revealing a therapeutic target for MYC-driven diseases.

DOI 10.64898/2026.05.05.723058

mouseexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivPreprintOct 28, 2025

The free fatty acid 2 receptor regulates the activation potency of C5a and the sensitivity to the antagonist avacopan

Zahra Khan, Neil Levin, Cláes Dahlgren…·Lena I Björkman

This study shows that the free fatty acid 2 receptor modulates C5a receptor signaling, enhancing NADPH oxidase activation and reducing the effect of the antagonist avacopan.

DOI 10.1101/2025.10.28.685092

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 20, 2025

BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complex

Kyrie Pappas, Matteo Ferrari, Perianne Smith…·Charles L. Sawyers

This study identifies loss of function mutations in the DNA pre-replication complex as a mechanism for PARP inhibitor resistance in BRCA-mutant prostate cancer, independent of reversion mutations.

1 citation

mouseorganoid / primary culture

𝕏 PostBluesky